Tuberculosis Diagnosis — Time for a Game Change
Open Access
- 9 September 2010
- journal article
- editorial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 363 (11), 1070-1071
- https://doi.org/10.1056/nejme1008496
Abstract
The effective treatment of tuberculosis is a lifesaving intervention. The global scale-up of tuberculosis therapy has averted 6 million deaths over the past 15 years, making it one of the greatest public health interventions of our lifetime.1 Unfortunately, by the time most patients are treated, they have already infected many others.2 This failure to interrupt transmission fuels the global epidemic so that every year there are more new cases of tuberculosis than in the previous year.1Keywords
This publication has 7 references indexed in Scilit:
- Rapid Molecular Detection of Tuberculosis and Rifampin ResistanceNew England Journal of Medicine, 2010
- Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practiceThe Lancet, 2010
- The Population Dynamics and Control of TuberculosisScience, 2010
- Tuberculosis control and elimination 2010–50: cure, care, and social developmentThe Lancet, 2010
- Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnosticsProceedings of the National Academy of Sciences of the United States of America, 2009
- Facing the Crisis: Improving the Diagnosis of Tuberculosis in the HIV EraThe Journal of Infectious Diseases, 2007
- Partnering for better microbial diagnosticsNature Biotechnology, 2006